|
1
|
Cerrato A, De Falco V and Santoro M:
Molecular genetics of medullary thyroid carcinoma: The quest for
novel therapeutic targets. J Mol Endocrinol. 43:143–155. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilliland FD, Hunt WC, Morris DM and Key
CR: Prognostic factors for thyroid carcinoma. A population-based
study of 15,698 cases from the Surveillance, Epidemiology and End
Results (SEER) program 1973–1991. Cancer. 79:564–573. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monson JP: The epidemiology of endocrine
tumours. Endocr Relat Cancer. 7:29–36. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kudo T, Miyauchi A, Ito Y, Takamura Y,
Amino N and Hirokawa M: Diagnosis of medullary thyroid carcinoma by
calcitonin measurement in fine-needle aspiration biopsy specimens.
Thyroid. 17:635–638. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jo VY, Renshaw AA and Krane JF: Relative
sensitivity of thyroid fine-needle aspiration by tumor type and
size. Diagn Cytopathol. 41:871–875. 2013.PubMed/NCBI
|
|
6
|
Trimboli P, Cremonini N, Ceriani L,
Saggiorato E, Guidobaldi L, Romanelli F, Ventura C, Laurenti O,
Messuti I, Solaroli E, et al: Calcitonin measurement in aspiration
needle washout fluids has higher sensitivity than cytology in
detecting medullary thyroid cancer: A retrospective multicentre
study. Clin Endocrinol. 80:135–140. 2014. View Article : Google Scholar
|
|
7
|
Pusztaszeri MP, Bongiovanni M and Faquin
WC: Update on the cytologic and molecular features of medullary
thyroid carcinoma. Adv Anat Pathol. 21:26–35. 2014. View Article : Google Scholar
|
|
8
|
Trimboli P, Treglia G, Guidobaldi L,
Romanelli F, Nigri G, Valabrega S, Sadeghi R, Crescenzi A, Faquin
WC, Bongiovanni M, et al: Detection rate of FNA cytology in
medullary thyroid carcinoma: A meta-analysis. Clin Endocrinol.
82:280–285. 2015. View Article : Google Scholar
|
|
9
|
Essig GF Jr, Porter K, Schneider D, Debora
A, Lindsey SC, Busonero G, Fineberg D, Fruci B, Boelaert K, Smit
JW, et al: Fine needle aspiration and medullary thyroid carcinoma:
The risk of inadequate preoperative evaluation and initial surgery
when relying upon FNAB cytology alone. Endocr Pract. 19:920–927.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee S, Shin JH, Han BK and Ko EY:
Medullary thyroid carcinoma: Comparison with papillary thyroid
carcinoma and application of current sonographic criteria. AJR Am J
Roentgenol. 194:1090–1094. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi N, Moon WJ, Lee JH, Baek JH, Kim DW
and Park SW: Ultrasonographic findings of medullary thyroid cancer:
Differences according to tumor size and correlation with fine
needle aspiration results. Acta Radiol. 52:312–316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SH, Kim BS, Jung SL, Lee JW, Yang PS,
Kang BJ, Lim HW, Kim JY, Whang IY, Kwon HS, et al: Ultrasonographic
findings of medullary thyroid carcinoma: A comparison with
papillary thyroid carcinoma. Korean J Radiol. 10:101–105. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trimboli P, Nasrollah N, Amendola S, Rossi
F, Ramacciato G, Romanelli F, Aurello P, Crescenzi A, Laurenti O,
Condorelli E, et al: Should we use ultrasound features associated
with papillary thyroid cancer in diagnosing medullary thyroid
cancer? Endocr J. 59:503–508. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andrioli M, Trimboli P, Amendola S,
Valabrega S, Fukunari N, Mirella M and Persani L: Elastographic
presentation of medullary thyroid carcinoma. Endocrine. 45:153–155.
2014. View Article : Google Scholar
|
|
15
|
Fukushima M, Ito Y, Hirokawa M, Miya A,
Kobayashi K, Akasu H, Shimizu K and Miyauchi A: Excellent prognosis
of patients with nonhereditary medullary thyroid carcinoma with
ultrasonographic findings of follicular tumor or benign nodule.
World J Surg. 33:963–968. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Trimboli P, Giovanella L, Valabrega S,
Andrioli M, Baldelli R, Cremonini N, Rossi F, Guidobaldi L,
Barnabei A, Rota F, et al: Ultrasound features of medullary thyroid
carcinoma correlate with cancer aggressiveness: A retrospective
multicenter study. J Exp Clin Cancer Res. 33:872014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trimboli P and Giovanella L: Serum
calcitonin negative medullary thyroid carcinoma: A systematic
review of the literature. Clin Chem Lab Med. 53:1507–1514. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rubello D, Rampin L, Nanni C, Banti E,
Ferdeghini M, Fanti S, Al-Nahhas A and Gross MD: The role of
18F-FDG PET/CT in detecting metastatic deposits of
recurrent medullary thyroid carcinoma: A prospective study. Eur J
Surg Oncol. 34:581–586. 2008. View Article : Google Scholar
|
|
19
|
Goldenberg DM, DeLand F, Kim E, Bennett S,
Primus FJ, van Nagell JR Jr, Estes N, DeSimone P and Rayburn P: Use
of radiolabeled antibodies to carcinoembryonic antigen for the
detection and localization of diverse cancers by external
photo-scanning. N Engl J Med. 298:1384–1386. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blottière HM, Steplewski Z, Herlyn D and
Douillard JY: Human anti-murine immunoglobulin responses and immune
functions in cancer patients receiving murine monoclonal antibody
therapy. Hum Antibodies Hybridomas. 2:16–25. 1991.PubMed/NCBI
|
|
21
|
Bird RE, Hardman KD, Jacobson JW, Johnson
S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS and Whitlow M:
Single-chain antigen-binding proteins. Science. 242:423–426. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subedi GP, Satoh T, Hanashima S, Ikeda A,
Nakada H, Sato R, Mizuno M, Yuasa N, Fujita-Yamaguchi Y and
Yamaguchi Y: Overproduction of anti-Tn antibody MLS128 single-chain
Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI
vector. Protein Expr Purif. 82:197–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marasco WA and Dana Jones S: Antibodies
for targeted gene therapy: Extracellular gene targeting and
intracellular expression. Adv Drug Deliv Rev. 31:153–170. 1998.
View Article : Google Scholar
|
|
24
|
Leyton JV, Olafsen T, Sherman MA, Bauer
KB, Aghajanian P, Reiter RE and Wu AM: Engineered humanized
diabodies for microPET imaging of prostate stem cell
antigen-expressing tumors. Protein Eng Des Sel. 22:209–216. 2009.
View Article : Google Scholar :
|
|
25
|
Pavlinkova G, Booth BJ, Batra SK and
Colcher D: Radio-immunotherapy of human colon cancer xenografts
using a dimeric single-chain Fv antibody construct. Clin Cancer
Res. 5:2613–2619. 1999.PubMed/NCBI
|
|
26
|
Marks JD, Hoogenboom HR, Bonnert TP,
McCafferty J, Griffiths AD and Winter G: By-passing immunization.
Human antibodies from V-gene libraries displayed on phage. J Mol
Biol. 222:581–597. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Osbourn J, Jermutus L and Duncan A:
Current methods for the generation of human antibodies for the
treatment of autoimmune diseases. Drug Discov Today. 8:845–851.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Puleo S, Mauro L, Gagliano G, Lombardo R,
Li Destri G, Petrillo G and Di Carlo I: Liver damage after
transarterial chemoembolization without embolizing agent in
unresectable hepatocellular carcinoma. Tumori. 89:285–287.
2003.PubMed/NCBI
|
|
29
|
Chung KY and Saltz LB: Antibody-based
therapies for colorectal cancer. Oncologist. 10:701–709. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Staelens S, Desmet J, Ngo TH, Vauterin S,
Pareyn I, Barbeaux P, Van Rompaey I, Stassen JM, Deckmyn H and
Vanhoorelbeke K: Humanization by variable domain resurfacing and
grafting on a human IgG4, using a new approach for
determination of non-human like surface accessible framework
residues based on homology modelling of variable domains. Mol
Immunol. 43:1243–1257. 2006. View Article : Google Scholar
|
|
31
|
Beckmann C, Brittnacher M, Ernst R,
Mayer-Hamblett N, Miller SI and Burns JL: Use of phage display to
identify potential Pseudomonas aeruginosa gene products relevant to
early cystic fibrosis airway infections. Infect Immun. 73:444–452.
2005. View Article : Google Scholar :
|
|
32
|
Sidhu SS, Lowman HB, Cunningham BC and
Wells JA: Phage display for selection of novel binding peptides.
Methods Enzymol. 328:333–363. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hegmans JP, Radosevic K, Voerman JS,
Burgers JA, Hoogsteden HC and Prins JB: A model system for
optimising the selection of membrane antigen-specific human
antibodies on intact cells using phage antibody display technology.
J Immunol Methods. 262:191–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Foy BD, Killeen GF, Frohn RH, Impoinvil D,
Williams A and Beier JC: Characterization of a unique human
single-chain antibody isolated by phage-display selection on
membrane-bound mosquito midgut antigens. J Immunol Methods.
261:73–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
